Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Biocept Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 26 | 11 | −15 |
| Shares | 899.3K | 80.0K | −819.3K (−91.1%) |
| Value | $304.2K | $96.4K | −$207.8K (−68.3%) |
New holders (3)
Institutions that held Biocept Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 44,861 | $54.3K | 0.02% |
| Boothbay Fund Management, LLC | 23,529 | $28.5K | 0.00% |
| JPMorgan Chase & Co | 268 | $324 | 0.00% |
Sold out (18)
Institutions that held Biocept Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Renaissance Technologies LLC | 193,741 | $66.0K |
| Geode Capital Management, LLC | 134,112 | $45.6K |
| Bridgeway Capital Management, LLC | 94,200 | $32.0K |
| HRT Financial LP | 55,334 | $18.0K |
| State Street Corp | 40,596 | $13.8K |
| Sabby Management, LLC | 29,602 | $10.1K |
| Northern Trust Corp | 26,818 | $9.12K |
| Taylor & Morgan Wealth Management, LLC | 26,000 | $8.84K |
| Jane Street Group, LLC | 25,403 | $8.64K |
| Susquehanna International Group, LLP | 22,477 | $7.64K |
| Ergoteles LLC | 22,020 | $7.49K |
| Ameriprise Financial Inc | 11,602 | $3.94K |
| Goldman Sachs Group Inc | 10,903 | $3.71K |
| Citadel Advisors LLC | 8,209 | $2.79K |
| UBS Group AG | 4,412 | $1.50K |
| FMR LLC | 20 | $7 |
| Simplex Trading, LLC | 475 | $0 |
| Focused Wealth Management, Inc | 1 | $0 |